Andrew Jacob Lenneman

Andrew Lenneman practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Andrew Lenneman's NPI, 1932399318, was assigned on July 31, 2007. Andrew Lenneman graduated from Wayne State University School of Medicine in 2004. Andrew Lenneman holds Alabama license 36407.

Andrew Lenneman's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Andrew Lenneman's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Andrew Lenneman is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrew Lenneman practices. Vendor and product names are available with a free account.

Cardiovascular disease is Andrew Lenneman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Andrew Lenneman is licensed in Alabama.

CMS data shows 857 Medicare services from Andrew Lenneman across 8 procedure codes in 2024, for 269 Medicare patients. Medicare paid $47,150 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 269 Medicare patients who saw Andrew Lenneman in 2024. The largest group is under 65, with 96 patients. 75% of them have heart failure, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Andrew Lenneman's median patient age at 61, with 50% women.

In 2024, Andrew Lenneman wrote 2,742 Medicare Part D claims for 495 patients. 75% of them were for generic drugs. CMS names the drug for 2,381 of them, across 44 drugs with 11 or more claims each, at $2,999,635 in total drug cost. In 2023, CMS named 2,856 claims across 51 drugs.

Andrew Lenneman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Andrew Lenneman, published from 2012 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Heart Failure, Heart Transplantation and Heart-Assist Devices. Andrew Lenneman has published most often in Am J Cardiol. Andrew Lenneman's most frequent co-authors are Joanna Marie Joly, MD, Jose A. Tallaj and Salpy Veronica Pamboukian, MD.

Dmand AI links Andrew Lenneman to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Diseases, Mitral Valve Insufficiency and Cardiovascular Diseases.

CMS Open Payments shows 31 general payments to Andrew Lenneman from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $891.

Andrew Lenneman graduated from Wayne State University School of Medicine in 2004.